Fluphenazine decanoate maintenance in schizophrenia: a retrospective study

Area of Science:

• Psychiatry and Mental Health
• Pharmacology
• Clinical Medicine

Background:

• Schizophrenia is a chronic mental disorder requiring long-term management.
• Hospitalization is a common intervention for managing acute exacerbations of schizophrenia.
• Effective long-term pharmacotherapy is crucial for reducing relapse rates and improving patient outcomes.

Purpose of the Study:

• To evaluate the effectiveness of long-acting fluphenazine decanoate injections in reducing hospital admissions and length of stay in schizophrenic patients.
• To assess the impact of sustained-release antipsychotic treatment on the management of schizophrenia.

Main Methods:

• A mirror image study design was employed.
• The study included 43 patients diagnosed with schizophrenia.
• Data on hospital admissions and length of stay were collected and compared before and after the initiation of fluphenazine decanoate injections.

Main Results:

• Long-acting fluphenazine decanoate injections demonstrated a significant reduction in hospital admissions among schizophrenic patients.
• The length of hospital stay for patients receiving fluphenazine decanoate was significantly decreased.
• The findings indicate a positive impact of the treatment on reducing the burden of psychiatric hospitalization.

Conclusions:

• Long-acting fluphenazine decanoate injections are an effective treatment strategy for reducing hospitalizations in schizophrenia.
• Sustained-release antipsychotic therapy can improve clinical management and reduce healthcare resource utilization for schizophrenia patients.
• This treatment modality offers a valuable option for long-term maintenance therapy in schizophrenia.